You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
New Brunswick, New Jersey
52 Week High
52 Week Low
Jack Kramer & Nick MartellManaging Editors of News & Snacks at Robinhood Financial LLC
Nonprofits urge Johnson & Johnson to halt sales of Baby Powder globally
Bottles of Johnson's baby powder are displayed in a store in New York By Carl O'Donnell (Reuters) - More than 170 nonprofit groups on Wednesday called for Joh
Potential COVID-19 vaccine not 'single solution' to pandemic, Johnson & Johnson CEO says
FILE PHOTO: Alex Gorsky, chairman and CEO of Johnson & Johnson, takes the stand as a witness in New Jersey Supreme Court in New Brunswick, New Jersey, U.S., Jan
$1.47 per share
Available Jul 16, Pre-Market
Johnson & Johnson cuts price of TB drug bedaquiline in poorer countries
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo (Reuters) - Johnson & Johnson (J
Catalent plant in Italy will help produce J&J's potential COVID-19 vaccine - minister
ROME, July 6 (Reuters) - A plant in Italy owned by U.S. group Catalent will help produce the potential COVID-19 vaccine being developed by drugmaker Johnson & J
Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J
Shares of Emergent BioSolutions Inc. EBS, +2.64% were up 1.1% in premarket trading on Monday after it announced a five-year deal with Johnson & Johnson JNJ, +0.
Emergent signs five-year deal backing J&J COVID-19 vaccine
FILE PHOTO: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration t
BRIEF-Emergent Biosolutions Says Will Begin Providing Large-Scale Drug Substance Manufacturing For Johnson & Johnson's Adenovirus-Based Covid-19 Vaccine In 2021
July 6 (Reuters) - Emergent BioSolutions Inc: * EMERGENT BIOSOLUTIONS SIGNS FIVE-YEAR AGREEMENT FOR LARGE-SCALE DRUG SUBSTANCE MANUFACTURING FOR JOHNSON & JOHN